| Authors: |
Mathiasen S; Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Palmisano T; Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Perry NA; Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Stoveken HM; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA., Vizurraga A; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA., McEwen DP; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA., Okashah N; Department of Pharmacology and Toxicology, Augusta University Medical College of Georgia, Augusta, GA, USA., Langenhan T; Rudolf Schönheimer Institute of Biochemistry, Division of General Biochemistry, Medical Faculty, Leipzig University, Leipzig, Germany., Inoue A; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan., Lambert NA; Department of Pharmacology and Toxicology, Augusta University Medical College of Georgia, Augusta, GA, USA., Tall GG; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA., Javitch JA; Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA. jaj2@columbia.edu.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA. jaj2@columbia.edu.; Department of Pharmacology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA. jaj2@columbia.edu. |
